Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Nick who wrote (598)	3/1/1998 5:18:00 AM
From: RavBruce	Respond to of 1580

Merck very rarely does credit offers and they are quickly bought by institutions seeking safety. You can't beat there long-term consistency in earnings and their relatively conservative management. I would trust Merck's mgt. when they say that they intend to remain independent and not make any large purchases or merge. I am not convinced that mega-mergers are good for the long-term. Mgt., the bankers, the lawyers, etc do very well and short-term investors do well. You end up with stock in a company that you might not want. And the company has to have bigger blockbuster drugs for it to mean anything. The only takeover that has been better than the original for my family is when my father bought MEDCO stock and then got Merck at way below market. Bruce